Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101

Cancer Statistics, 2001

Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337

Delineation of prognostic biomarkers in prostate cancer

Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R. B., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,675

Is a p53-Regulated Inhibitor of G2/M Progression

Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126

Specific protection against breast cancers by cyclin D1 ablation

Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Chang, K., & Pastan, I. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 747

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

Reiter, R. E., Gu, Z., Watabe, T., THOMAS, G. V., Szigeti, K., Davis, E., Wahl, M. I., Nisitani, S., Yamashiro, J. M., Beau, M. M. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 675

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659

α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer

Rubin, M. A. (2002) · JAMA · doi:10.1001/jama.287.13.1662 · Cited by 643

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Wilentz, R. E., Iacobuzio–Donahue, C. A., Argani, P., McCarthy, D. M., Parsons, J. L., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · PubMed · Cited by 591

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574

Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints

Torhorst, J. K. H., Bucher, C., Kononen, J., Haas, P., Zuber, M., Köchli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M. J., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63075-1 · Cited by 565

14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis

van Hemert, M. J., Steensma, H. Y., & van Heusden, G. P. H. (2001) · BioEssays · doi:10.1002/bies.1134 · Cited by 535

Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor β-catenin Mutations

Abraham, S. C., Klimstra, D. S., Wilentz, R. E., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., Wu, T., & Hruban, R. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62563-1 · Cited by 484

Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays

Iacobuzio–Donahue, C. A., Maitra, A., Olsen, M. N., Lowe, A. W., van Heek, N. T., Rosty, C., Kim, W., Sato, N., Parker, A. R., Ashfaq, R., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 471

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 451

High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer

Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A.-T., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444

Tissue microarrays for gene amplification surveys in many different tumor types.

Schraml, P., Kononen, J., Bubendorf, L., Moch, H., Bissig, H., Nocito, A., Mihatsch, M. J., Kallioniemi, O., & Sauter, G. (1999) · PubMed · Cited by 433

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer

Barton, C., Staddon, S., Hughes, C., Hall, P., O'Sullivan, C., Klöppel, G., Theis, B. A., Russell, R. C. G., Neoptolemos, J. P., & Williamson, R. C. N. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.467 · Cited by 375

Genetic progression in the pancreatic ducts

Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373

Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia

van Heek, N. T., Meeker, A. K., Kern, S. E., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Offerhaus, G. J. A., Hicks, J. L., Wilentz, R. E., Goggins, M. G., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64432-x · Cited by 363

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Wilentz, R. E., Geradts, J., Maynard, R. D., Offerhaus, G. J. A., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., & Hruban, R. H. (1998) · PubMed · Cited by 337

Pancreatic adenocarcinomas frequently show p53 gene mutations.

Scarpa, A., Capelli, P., Mukai, K., Zamboni, G., Oda, T., Iacono, C., & Hirohashi, S. (1993) · PubMed Central · Cited by 332

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Argani, P., Rosty, C., Reiter, R. E., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Ryu, B., Skinner, H. G., Goggins, M., Jaffee, E. M., et al. (2001) · PubMed · Cited by 313

Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas

Wilentz, R. E., Su, G. H., Dai, J. L., Sparks, A. B., Argani, P., Sohn, T. A., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64703-7 · Cited by 304

bcl-1, t(11;14), and mantle cell-derived lymphomas [editorial]

Raffeld, M. A., & Jaffe, E. (1991) · Blood · doi:10.1182/blood.v78.2.259.bloodjournal782259 · Cited by 303

Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology

Iacobuzio–Donahue, C. A., Maitra, A., Shen-Ong, G. L. C., van Heek, N. T., Ashfaq, R., Meyer, R., Walter, K., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62551-5 · Cited by 294

The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis

Adsay, N., Merati, K., Andea, A., Sarkar, F., Hruban, R., Wilentz, R. E., Goggins, M., Iocobuzio-Donahue, C. A., Longnecker, D., & Klimstra, D. (2002) · Modern Pathology · doi:10.1097/01.mp.0000028647.98725.8b · Cited by 290

Genetic and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma

Abraham, S. C., Wu, T., Hruban, R. H., Lee, J.-H., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., & Klimstra, D. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64917-6 · Cited by 275

Distinctive Molecular Genetic Alterations in Sporadic and Familial Adenomatous Polyposis-Associated Pancreatoblastomas

Abraham, S. C., Wu, T., Klimstra, D. S., Finn, L. S., Lee, J.-H., Yeo, C. J., Cameron, J. L., & Hruban, R. H. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63008-8 · Cited by 270

The Immunohistochemical Mucin Expression Pattern Distinguishes Different Types of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Determines Their Relationship to Mucinous Noncystic Carcinoma and Ductal Adenocarcinoma

Lűttges, J., Zamboni, G., Longnecker, D., & Klöppel, G. (2001) · American Journal of Surgical Pathology · doi:10.1097/00000478-200107000-00014 · Cited by 267

Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.

Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N., & Beger, H. G. (1997) · PubMed · Cited by 261

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

Kim, G., Bae, H., Park, H., Kuan, S., Crawley, S., Ho, J. J. L., & Kim, Y. S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36018 · Cited by 252

Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis

Luettges, J., Galehdari, H., Bröcker, V., Schwarte‐Waldhoff, I., Henne‐Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma

Iwata, N., Yamamoto, H., Sasaki, S., Itoh, F., Suzuki, H., Kikuchi, T., Kaneto, H., Iku, S., Ozeki, I., Karino, Y., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203898 · Cited by 229

Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma

Fukushima, N., Sato, N., Ueki, T., Rosty, C., Walter, K., Wilentz, R. E., Yeo, C. J., Hruban, R. H., & Goggins, M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61104-2 · Cited by 225

Overexpression of p53 Protein in Adenocarcinoma of the Pancreas

DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van den Berg, F. M., Allison, D. C., Cameron, J. L., & Offerhaus, G. J. A. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.6.684 · Cited by 217

BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial Neoplasia

Goggins, M., Hruban, R. H., & Kern, S. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65047-x · Cited by 213

Expression of mucin antigens in human cancers and its relationship with malignancy potential

Yonezawa, S., & Sato, E. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb03713.x · Cited by 207

Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.

Østergaard, M., Rasmussen, H. H., Nielsen, H. V., Vorum, H., Orntoft, T. F., Wolf, H., & Celis, J. E. (1997) · PubMed · Cited by 206

Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.

Pandey, P., Kharbanda, S. M., & Kufe, D. W. (1995) · PubMed · Cited by 189

Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.

Ruggeri, B., Zhang, S.-Y., Caamaño, J., DiRado, M., Flynn, S. D., & Klein–Szanto, A. J. (1992) · PubMed · Cited by 172

Genetic Progression and Divergence in Pancreatic Carcinoma

Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., & Shirai, T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65083-3 · Cited by 160

Cyclooxygenase 2 Expression in Pancreatic Adenocarcinoma and Pancreatic Intraepithelial Neoplasia

Maitra, A., Ashfaq, R., Gunn, C. R., Rahman, A., Yeo, C. J., Sohn, T. A., Cameron, J. L., Hruban, R. H., & Wilentz, R. E. (2002) · American Journal of Clinical Pathology · doi:10.1309/tpg4-ck1c-9v8v-8awc · Cited by 159

Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.

Ryu, B., Jones, J., Blades, N. J., Parmigiani, G., Hollingsworth, M. A., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 154

Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.

Bouras, T., Southey, M. C., Chang, A. C.-M., Reddel, R. R., Willhite, D., Glynne, R. J., Henderson, M. A., Armes, J. E., & Venter, D. J. (2002) · PubMed · Cited by 153

Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer

Grothey, A. F., Hashizume, R., Şahin, A. A., & McCrea, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1395 · Cited by 148

Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.

Biankin, A. V., Kench, J. G., Morey, A. L., Lee, C. S. L., Biankin, S. A., Head, D. R., Hugh, T. B., Henshall, S. M., & Sutherland, R. L. (2001) · PubMed · Cited by 148

Expression of MUC1, MUC2, MUC3 and MUC4 mucin mrnas in human pancreatic and intestinal tumor cell lines

Hollingsworth, M. A., Strawhecker, J. M., Caffrey, T. C., & Mack, D. R. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570212 · Cited by 142

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis

Apple, S. K., Hecht, J. R., Lewin, D., Jahromi, S. A., Grody, W. W., & Nieberg, R. K. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90265-4 · Cited by 133

Immunohistochemical Validation of a Novel Epithelial and a Novel Stromal Marker of Pancreatic Ductal Adenocarcinoma Identified by Global Expression Microarrays

Maitra, A., Iacobuzio–Donahue, C. A., Rahman, A., Sohn, T. A., Argani, P., Meyer, R., Yeo, C. J., Cameron, J. L., Goggins, M., Kern, S. E., et al. (2002) · American Journal of Clinical Pathology · doi:10.1309/3pam-p5wl-2lv0-r4eg · Cited by 132

Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of Progression

Klein, W. M., Hruban, R. H., Klein–Szanto, A. J., & Wilentz, R. E. (2002) · Modern Pathology · doi:10.1038/modpathol.3880544 · Cited by 131

Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers.

Ryu, B., Jones, J., Hollingsworth, M. A., Hruban, R. H., & Kern, S. E. (2001) · PubMed · Cited by 119

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco, M., Bell, A. K., Heath, V. L., Sullivan, A., Smith, P., Hiller, L., Yuluğ, I. G., Numico, G., Merlano, M. C., Farrell, P. J., et al. (2002) · PubMed · Cited by 118

Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.

Kornmann, M., Danenberg, K. D., Arber, N., Beger, H. G., Danenberg, P. V., & Korc, M. (1999) · PubMed · Cited by 113

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

Hu, W., McCrea, P. D., Deavers, M. T., Kavanagh, J. J., Kudelka, A. P., & Verschraegen, C. F. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1026596609969 · Cited by 107

The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes

Moravski, C. J., Skinner, S. L., Stubbs, A. J., Sarlos, S., Kelly, D. J., Cooper, M. E., Gilbert, R. E., & Wilkinson‐Berka, J. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63806-0 · Cited by 95

Increased Cyclin D1 in Human Pancreatic Cancer Is Associated with Decreased Postoperative Survival

Kornmann, M., Ishiwata, T., Itakura, J., Tangvoranuntakul, P., Beger, H. G., & Korc, M. (1998) · Oncology · doi:10.1159/000011879 · Cited by 95

TAP1 down-regulation in primary melanoma lesions: An independent marker of poor prognosis

Kamarashev, J. A., Ferrone, S., Seifert, B., B�ni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1 · Cited by 79

Involvement of the MAP kinase ERK2 in MUC1 mucin signaling

Meerzaman, D. M., Shapiro, P. S., & Kim, K. C. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l86 · Cited by 78

Expression of cyclin D1 and retinoblastoma protein in colorectal cancer

Palmqvist, R., Stenling, R., Öberg, Å., & Landberg, G. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00162-2 · Cited by 77

Pathology of incipient pancreatic cancer

Hruban, R. H., Wilentz, R. E., Goggins, M., Offerhaus, G. J. A., Yeo, C. J., & Kern, S. E. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s9 · Cited by 76

Analysis of β-Catenin Gene Mutations in Pancreatic Tumors

Gerdes, B., Ramaswamy, A., Simon, B., Pietsch, T., Bastian, D., Kersting, M., Moll, R., & Bartsch, D. K. (1999) · Digestion · doi:10.1159/000007704 · Cited by 74

Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.

Zhang, S. Y., Ruggeri, B., Agarwal, P., Sorling, A. F., Obara, T., Ura, H., Namiki, M., & Klein–Szanto, A. J. (1994) · PubMed · Cited by 73

Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.

Hassan, R., Lerner, M. R., Benbrook, D. M., Lightfoot, S. A., Brackett, D. J., Wang, Q.-C., & Pastan, I. H. (2002) · PubMed · Cited by 70

Prevention of Pancreatic Cancer and Strategies for Management of Familial Pancreatic Cancer

Hruban, R. H., Canto, M. I., & Yeo, C. J. (2001) · Digestive Diseases · doi:10.1159/000050656 · Cited by 61

REVIEW ARTICLE. p53: GUARDIAN OF CELLULAR SENESCENCE

Wynford‐Thomas, D. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199610)180:2 · Cited by 60

Pathology of Cancer of the Pancreas

Wilentz, R. E., & Hruban, R. H. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30284-9 · Cited by 50

Epidermal Growth Factor Induces Cyclin D1 in Human Pancreatic Carcinoma: Evidence for a Cyclin D1–Dependent Cell Cycle Progression

Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T. T. W., Schnelldorfer, T., Ramadani, M., Beger, H. G., & Gansauge, S. (2001) · Pancreas · doi:10.1097/00006676-200110000-00009 · Cited by 48

Aberrant Expression of Tumor Suppressor Proteins in the Ewing Family of Tumors

Maitra, A., Roberts, H., Weinberg, A. G., & Geradts, J. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1207-aeotsp · Cited by 48

Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.

Fan, D., Yano, S., Shinohara, H., Solórzano, C. C., Arsdall, M. R. V., Bucana, C. D., Pathak, S., Kruzel, E., Herbst, R. S., Onn, A., et al. (2002) · PubMed · Cited by 42

p53 mutations in sweat gland carcinomas

Biernat, W., Peraud, A., Wozniak, L., & Ohgaki, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980504)76:3 · Cited by 40

Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors.

de Bolós, C. (2001) · Frontiers in bioscience · doi:10.2741/bolos · Cited by 37

Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.

Mäkinen, K., Hakala, T., Lipponen, P., ALHAVA, E. M., & Eskelinen, M. J. (1998) · PubMed · Cited by 34

The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the Lung

Anton, R. C., Coffey, D. M., Gondo, M., Stephenson, M. A., Brown, R. W., & Cagle, P. T. (2000) · Modern Pathology · doi:10.1038/modpathol.3880215 · Cited by 32

Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material

Linder, S., Parrado, C., Falkmer, S., Blåsjö, M., Sundelin, P., & von Rosen, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.336 · Cited by 32

De novo Expression of the Muc2 Gene in Pancreas Carcinoma Cells Is Triggered by Promoter Demethylation

Siedow, A., Moshe Szyf, A., Gratchev, A. N., Kobalz, U., Hanski, M. L., Bumke‐Vogt, C., Foss, H., Riecken, E. O., & HANSKI, C. (2002) · Tumor Biology · doi:10.1159/000048689 · Cited by 26

Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel‐Lindau tumor suppressor‐binding protein (CUL2 and VBP1) mutation and loss in renal‐cell carcinoma development

Clifford, S. C., Walsh, S., Hewson, K., Green, E., Brinke, A., Green, P. M., Gianelli, F., Eng, C., & Maher, E. R. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199909)26:1 · Cited by 22

Regulation of mucin and glycoconjugate expression from normal epithelium to gastric tumors

de Bolós, C. (2001) · Frontiers in bioscience · doi:10.2741/a678 · Cited by 8

Pancreatic cancer

Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212

Genetics and biology of pancreatic ductal adenocarcinomaPreprint

Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,611

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321

An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091

Phenotype and Genotype of Pancreatic Cancer Cell Lines

Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936

Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions

Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., Gress, T. M., & Krebshilfe, F. T. G. P. C. N. O. T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208804 · Cited by 190

Pancreatic intra-epithelial neoplasia: current clinicopathological and molecular considerations

Andea, A. A., Baştürk, O., & Adsay, V. N. (2005) · Current Diagnostic Pathology · doi:10.1016/j.cdip.2004.11.008 · Cited by 2

MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia

Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., & Argani, P. (2002) · American Journal of Clinical Pathology · doi:10.1309/7y7n-m1wm-r0yk-m2va · Cited by 238

Update on pancreatic intraepithelial neoplasia.

Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269